Talk to Robyn

00 1 718 213 49 04

Search inside this page

Publishers

All regions

Free Market Research Guides to Download

Pharmaceutical Analysis & Statistics, May 2013 (p5)

You might be interested in: therapeutics, cancer, drug, more »

» Purchase Premium Reports

121-160 of about 26 000 reports
Ribavirin  - Comprehensive patent search

Ribavirin - Comprehensive patent search

  • $ 7 200
  • Company report
  • May 2013
  • by GenericsWeb

Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Develope ...

  • Industries : Generic Drug
Ritonavir  - Comprehensive patent search

Ritonavir - Comprehensive patent search

  • $ 7 200
  • Company report
  • May 2013
  • by GenericsWeb

Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Develope ...

  • Industries : Generic Drug
Daptomycin   - Comprehensive patent search

Daptomycin - Comprehensive patent search

  • $ 7 200
  • Company report
  • May 2013
  • by GenericsWeb

Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Develope ...

  • Industries : Generic Drug
Aprela (Osteoporosis) - Forecast and Market Analysis to 2022

Aprela (Osteoporosis) - Forecast and Market Analysis to 2022

  • $ 6 995
  • Industry report
  • February 2013
  • by Global Data

Aprela (Osteoporosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Aprela (Osteoporosis) - Forecast and Market Analysis to 2022?. ...

  • Industries : Pathology
  • Countries : United States, World, Spain, Italy, France, Germany, Japan, Europe, United Kingdom
Evista (Osteoporosis) - Forecast and Market Analysis to 2022

Evista (Osteoporosis) - Forecast and Market Analysis to 2022

  • $ 6 995
  • Industry report
  • February 2013
  • by Global Data

Evista (Osteoporosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Evista (Osteoporosis) - Forecast and Market Analysis to 2022?. ...

  • Industries : Pathology
  • Countries : United States, World, Spain, Italy, France, Germany, Japan, India, China, Europe, United Kingdom
Romosozumab (Osteoporosis) - Forecast and Market Analysis to 2022

Romosozumab (Osteoporosis) - Forecast and Market Analysis to 2022

  • $ 6 995
  • Industry report
  • February 2013
  • by Global Data

Romosozumab (Osteoporosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Romosozumab (Osteoporosis) - Forecast and Market Analysis ...

  • Industries : Pathology
  • Countries : World, United States, Spain, Italy, France, Germany, Japan, Europe, United Kingdom
Recalbon/Bonoteo (Osteoporosis) - Forecast and Market Analysis to 2022

Recalbon/Bonoteo (Osteoporosis) - Forecast and Market Analysis to 2022

  • $ 6 995
  • Industry report
  • February 2013
  • by Global Data

Recalbon/Bonoteo (Osteoporosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Recalbon/Bonoteo (Osteoporosis) - Forecast and Market ...

  • Industries : Pathology
  • Countries : Japan, United States, World
BA-058 (Osteoporosis) - Forecast and Market Analysis to 2022

BA-058 (Osteoporosis) - Forecast and Market Analysis to 2022

  • $ 6 995
  • Industry report
  • February 2013
  • by Global Data

BA-058 (Osteoporosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?BA-058 (Osteoporosis) - Forecast and Market Analysis to 2022?. ...

  • Industries : Pathology
  • Countries : World, United States, Spain, Italy, France, Germany, Japan, Europe, United Kingdom
Ostora (Osteoporosis) - Forecast and Market Analysis to 2022

Ostora (Osteoporosis) - Forecast and Market Analysis to 2022

  • $ 6 995
  • Industry report
  • February 2013
  • by Global Data

Ostora (Osteoporosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Ostora (Osteoporosis) - Forecast and Market Analysis to 2022?. ...

  • Industries : Pathology
  • Countries : World, United States, Japan, China
Viviant/Combriza (Osteoporosis) - Forecast and Market Analysis to 2022

Viviant/Combriza (Osteoporosis) - Forecast and Market Analysis to 2022

  • $ 6 995
  • Industry report
  • February 2013
  • by Global Data

Viviant/Combriza (Osteoporosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Viviant/Combriza (Osteoporosis) - Forecast and Market ...

  • Industries : Pathology
  • Countries : Spain, Italy, Japan, United States, World
Protelos (Osteoporosis) - Forecast and Market Analysis to 2022

Protelos (Osteoporosis) - Forecast and Market Analysis to 2022

  • $ 6 995
  • Industry report
  • February 2013
  • by Global Data

Protelos (Osteoporosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Protelos (Osteoporosis) - Forecast and Market Analysis to 2022?. ...

  • Industries : Pathology
  • Countries : France, World, Spain, Italy, Germany, Japan, India, China, Europe, United States, United Kingdom
Odanacatib (Osteoporosis) - Forecast and Market Analysis to 2022

Odanacatib (Osteoporosis) - Forecast and Market Analysis to 2022

  • $ 6 995
  • Industry report
  • February 2013
  • by Global Data

Odanacatib (Osteoporosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Odanacatib (Osteoporosis) - Forecast and Market Analysis ...

  • Industries : Pathology
  • Countries : World, United States, Spain, Italy, France, Germany, Japan, Europe, United Kingdom
PTH(1-31)NH2 (Osteoporosis) - Forecast and Market Analysis to 2022

PTH(1-31)NH2 (Osteoporosis) - Forecast and Market Analysis to 2022

  • $ 6 995
  • Industry report
  • February 2013
  • by Global Data

PTH(1-31)NH2 (Osteoporosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?PTH(1-31)NH2 (Osteoporosis) - Forecast and Market Analysis ...

  • Industries : Pathology
  • Countries : World, United States, Spain, Italy, France, Germany, Europe, United Kingdom
Forteo (Osteoporosis) - Forecast and Market Analysis to 2022

Forteo (Osteoporosis) - Forecast and Market Analysis to 2022

  • $ 6 995
  • Industry report
  • February 2013
  • by Global Data

Forteo (Osteoporosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Forteo (Osteoporosis) - Forecast and Market Analysis to 2022?. ...

  • Industries : Pathology
  • Countries : World, United States, Spain, Italy, France, Germany, Japan, India, China, Europe, United Kingdom
Reclast (Osteoporosis) - Forecast and Market Analysis to 2022

Reclast (Osteoporosis) - Forecast and Market Analysis to 2022

  • $ 6 995
  • Industry report
  • February 2013
  • by Global Data

Reclast (Osteoporosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Reclast (Osteoporosis) - Forecast and Market Analysis to 2022?. ...

  • Industries : Pathology
  • Countries : World, United States, Spain, Italy, France, Germany, Japan, India, China, Europe, United Kingdom
Actonel (Osteoporosis) - Forecast and Market Analysis to 2022

Actonel (Osteoporosis) - Forecast and Market Analysis to 2022

  • $ 6 995
  • Industry report
  • February 2013
  • by Global Data

Actonel (Osteoporosis) - Forecast and Market Analysis to 2022 Summary GlobalData has released its new PharmaPoint Drug Evaluation report, ?Actonel (Osteoporosis) - Forecast and Market Analysis to 2022?. ...

  • Industries : Pathology
Ivabradine  - Comprehensive patent search

Ivabradine - Comprehensive patent search

  • $ 6 400
  • Company report
  • May 2013
  • by GenericsWeb

Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Develope ...

  • Industries : Generic Drug
Cefditoren  - Comprehensive patent search

Cefditoren - Comprehensive patent search

  • $ 6 400
  • Company report
  • May 2013
  • by GenericsWeb

Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Develope ...

  • Industries : Generic Drug
Eptifibatide  - Comprehensive patent search

Eptifibatide - Comprehensive patent search

  • $ 6 400
  • Company report
  • May 2013
  • by GenericsWeb

Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Develope ...

  • Industries : Generic Drug
Vilazodone  - Comprehensive patent search

Vilazodone - Comprehensive patent search

  • $ 6 400
  • Company report
  • May 2013
  • by GenericsWeb

Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Develope ...

  • Industries : Generic Drug
Almotriptan  - Comprehensive patent search

Almotriptan - Comprehensive patent search

  • $ 6 400
  • Company report
  • May 2013
  • by GenericsWeb

Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Develope ...

  • Industries : Generic Drug
Tofacitinib   - Comprehensive patent search

Tofacitinib - Comprehensive patent search

  • $ 6 400
  • Company report
  • May 2013
  • by GenericsWeb

Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Develope ...

  • Industries : Generic Drug
Pioglitazone  - Comprehensive patent search

Pioglitazone - Comprehensive patent search

  • $ 6 400
  • Company report
  • May 2013
  • by GenericsWeb

Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Develope ...

  • Industries : Generic Drug
Itraconazole  - Comprehensive patent search

Itraconazole - Comprehensive patent search

  • $ 6 400
  • Company report
  • May 2013
  • by GenericsWeb

Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Develope ...

  • Industries : Generic Drug
Caspofungin  - Comprehensive patent search

Caspofungin - Comprehensive patent search

  • $ 6 400
  • Company report
  • May 2013
  • by GenericsWeb

Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Develope ...

  • Industries : Generic Drug
Carfilzomib   - Comprehensive patent search

Carfilzomib - Comprehensive patent search

  • $ 6 400
  • Company report
  • May 2013
  • by GenericsWeb

Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Develope ...

  • Industries : Generic Drug
Entecavir  - Comprehensive patent search

Entecavir - Comprehensive patent search

  • $ 6 400
  • Company report
  • May 2013
  • by GenericsWeb

Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Develope ...

  • Industries : Generic Drug
Aliskiren  - Comprehensive patent search

Aliskiren - Comprehensive patent search

  • $ 6 400
  • Company report
  • May 2013
  • by GenericsWeb

Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Develope ...

  • Industries : Generic Drug
Penciclovir  - Comprehensive patent search

Penciclovir - Comprehensive patent search

  • $ 6 400
  • Company report
  • May 2013
  • by GenericsWeb

Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Develope ...

  • Industries : Generic Drug
Tiotropium Bromide  - Comprehensive patent search

Tiotropium Bromide - Comprehensive patent search

  • $ 6 400
  • Company report
  • May 2013
  • by GenericsWeb

Imagine having your own team of pharmaceutical patent experts, at a fraction of the cost and without the wait. Used by the worlds leading generic pharmaceutical companies and legal teams, Pipeline Develope ...

  • Industries : Generic Drug

Algeria Poisonings, 45-59 Yrs, Male, Dalys

  • $ 250
  • Industry data
  • May 2013

Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research

  • Industries : Pharmaceutical
  • Countries : Algeria

Guyana Poisonings, 45-59 Yrs, Male, Dalys

  • $ 250
  • Industry data
  • May 2013

Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research

  • Industries : Pharmaceutical
  • Countries : Guyana

South Korea Poisonings, 45-59 Yrs, Male, Dalys

  • $ 250
  • Industry data
  • May 2013

Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research

  • Industries : Pharmaceutical
  • Countries : South Korea

Belarus Poisonings, 45-59 Yrs, Male, Dalys

  • $ 250
  • Industry data
  • May 2013

Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research

  • Industries : Pharmaceutical
  • Countries : Belarus

Mauritius Poisonings, 45-59 Yrs, Male, Dalys

  • $ 250
  • Industry data
  • May 2013

Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research

  • Industries : Pharmaceutical
  • Countries : Mauritius

Import Amount-pharmaceuticals-china-annual, In Usd (ten Thousands)

  • $ 250
  • Industry data
  • May 2013

Yearly, From 2000 To 2011
By Chinascope Financial
Source: Chinascope Financial

  • Industries : Pharmaceutical

Import Volume-pharmaceuticals-china-annual, In Tonne (units)

  • $ 250
  • Industry data
  • May 2013

Yearly, From 1996 To 2011
By Chinascope Financial
Source: Chinascope Financial

  • Industries : Pharmaceutical

Export Volume-pharmaceuticals-china-annual, In Tonne (units)

  • $ 250
  • Industry data
  • May 2013

Yearly, From 2000 To 2011
By Chinascope Financial
Source: Chinascope Financial

  • Industries : Pharmaceutical

Export Amount-pharmaceuticals-china-annual, In Usd (ten Thousands)

  • $ 250
  • Industry data
  • May 2013

Yearly, From 2000 To 2011
By Chinascope Financial
Source: Chinascope Financial

  • Industries : Pharmaceutical

Albania Poisonings, 45-59 Yrs, Male, Dalys

  • $ 250
  • Industry data
  • May 2013

Yearly, From 2005 To 2030
By Business Monitor International
Source: WHO, World Bank, IMF, BMI research

  • Industries : Pharmaceutical
  • Countries : Albania

» Read our Company Profiles

About 600 Companies

GlaxoSmithKline P.L.C.

United States

Novartis Inc.

Switzerland

GlaxoSmithKline PLC

United Kingdom

Pfizer Inc.

United States

Johnson and Johnson

United States

Privacy Policy by TRUSTe
ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.